Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
📊
Temel Bulgular & Veri:Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
💡
Sonuç & Katkı:Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:covid · vaccine · renal
Abstract
Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients Expected seroprotection rate after the sixth dose COVID-19 vaccine: a note from clinical model on kidney transplant recipients
Sookaromdee, P., Wiwanitkit, V. (2022). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi, Cilt: 85 Sayı: 4, 585–586. https://doi.org/10.26650/IUITFD.1133431
Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar